These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

482 related articles for article (PubMed ID: 16213290)

  • 21. Methotrexate for lung transplant recipients with steroid-resistant acute rejection.
    Cahill BC; O'Rourke MK; Strasburg KA; Savik K; Jessurun J; Bolman RM; Hertz MI
    J Heart Lung Transplant; 1996 Nov; 15(11):1130-7. PubMed ID: 8956122
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evidence demonstrating poor kidney graft survival when acute rejections are associated with IgG donor-specific lymphocytotoxin.
    Lobo PI; Spencer CE; Stevenson WC; Pruett TL
    Transplantation; 1995 Feb; 59(3):357-60. PubMed ID: 7871565
    [TBL] [Abstract][Full Text] [Related]  

  • 23. FK 506 in the treatment of steroid- and OKT3-resistant rejection in renal transplant recipients: reduced dosage and anti-infective prophylaxis.
    Kliem V; Eberhard OK; Oldhafer K; Schlitt HJ; Behrend M; Schaumann D; Pichlmayr R; Koch KM; Brunkhorst R
    Transplant Proc; 1996 Dec; 28(6):3166-8. PubMed ID: 8962227
    [No Abstract]   [Full Text] [Related]  

  • 24. Living donor kidney transplantation across positive crossmatch: the University of Illinois at Chicago experience.
    Thielke JJ; West-Thielke PM; Herren HL; Bareato U; Ommert T; Vidanovic V; Campbell-Lee SA; Tzvetanov IG; Sankary HN; Kaplan B; Benedetti E; Oberholzer J
    Transplantation; 2009 Jan; 87(2):268-73. PubMed ID: 19155983
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incidence and outcome of OKT3 treatment for early steroid-resistant rejection following hepatic transplantation.
    Lange D; Bechstein WO; Blumhardt G; Lemmens P; Schattenfroh N; Neuhaus P
    Transplant Proc; 1993 Apr; 25(2):1870-1. PubMed ID: 8470207
    [No Abstract]   [Full Text] [Related]  

  • 26. Tacrolimus rescue therapy for corticosteroid-resistant and polyclonal antibody-resistant kidney allograft rejections.
    Naderi GH; Mehraban D; Ganji MR; Yahyazadeh SR; Latif AH
    Urol J; 2009; 6(1):31-4. PubMed ID: 19241339
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [OKT3 treatment of refractory renal allograft rejection].
    Xu J; Ma J; Bai X
    Zhonghua Wai Ke Za Zhi; 1997 Apr; 35(4):223-5. PubMed ID: 10374543
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical and renal histologic predictors of long-term outcome after OKT3 therapy for steroid-resistant rejection.
    Wiener Y; Nakhleh RE; Kupin WL; Lee M; Escobar FS; Venkat KK; Mozes MF
    Transplant Proc; 1995 Feb; 27(1):1014-5. PubMed ID: 7878781
    [No Abstract]   [Full Text] [Related]  

  • 29. Treatment of steroid-resistant rejection with tacrolimus prior to OKT3 in liver transplant recipients.
    Millis JM; Bruce DS; Newell KA; Piper JB; Woodle ES; Seaman DS; Baker AL; Hart J; Dasgupta K; Thistlethwaite JR
    Transplant Proc; 1996 Apr; 28(2):1014. PubMed ID: 8623213
    [No Abstract]   [Full Text] [Related]  

  • 30. Sirolimus (rapamycin) reduces the incidence of acute rejection episodes in renal transplantation: an initial experience in Taiwan.
    Liu KL; Chu SH; Chiang YJ; Wu CT; Chen Y
    Transplant Proc; 2004 Sep; 36(7):2051-2. PubMed ID: 15518742
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Steroid-resistant acute rejections after liver transplant.
    Aydogan C; Sevmis S; Aktas S; Karakayali H; Demirhan B; Haberal M
    Exp Clin Transplant; 2010 Jun; 8(2):172-7. PubMed ID: 20565375
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Orthoclone OKT3 in the treatment of intractable acute renal allograft rejection].
    Yu LX
    Zhonghua Wai Ke Za Zhi; 1993 Dec; 31(12):754-5. PubMed ID: 8033708
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A randomized prospective study comparing low-dose OKT3 to low-dose ATG for the treatment of acute steroid-resistant rejection episodes in kidney transplant recipients.
    Mariat C; Alamartine E; Diab N; de Filippis JP; Laurent B; Berthoux F
    Transpl Int; 1998; 11(3):231-6. PubMed ID: 9638854
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Successful infliximab treatment of steroid and OKT3 refractory acute cellular rejection in two patients after intestinal transplantation.
    Pascher A; Radke C; Dignass A; Schulz RJ; Veltzke-Schlieker W; Adler A; Sauer IM; Platz K; Klupp J; Volk HD; Neuhaus P; Mueller AR
    Transplantation; 2003 Aug; 76(3):615-8. PubMed ID: 12923454
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tacrolimus rescue therapy in patients with rejection and long-term dialysis after kidney transplantation.
    Witzke O; Becker G; Erhard J; Lütkes P; Szabo A; Philipp T; Heemann U
    Clin Nephrol; 1998 Jan; 49(1):24-7. PubMed ID: 9491282
    [TBL] [Abstract][Full Text] [Related]  

  • 36. OKT3 therapy in addition to tacrolimus is associated with improved long-term function in patients with steroid refractory renal allograft rejection.
    Patschan D; Kribben A; Pietruck F; Lutz J; Binek M; Philipp T; Heemann U; Witzke O
    Nephron Clin Pract; 2006; 103(3):c94-9. PubMed ID: 16534238
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical experience with Muromonab-CD3 monoclonal antibody (OKT3) in heart transplantation.
    Macris MP; Frazier OH; Lammermeier D; Radovancevic B; Duncan JM
    J Heart Transplant; 1989; 8(4):281-7. PubMed ID: 2504894
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induction versus noninduction therapy in kidney transplantation: considering different PRA levels and different induction therapies.
    Castro MC; Araujo LM; Nahas WC; Arap S; David-Neto E; Ianhez LE
    Transplant Proc; 2004 May; 36(4):874-6. PubMed ID: 15194299
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Refractory acute kidney transplant rejection with CD20 graft infiltrates and successful therapy with rituximab.
    Alausa M; Almagro U; Siddiqi N; Zuiderweg R; Medipalli R; Hariharan S
    Clin Transplant; 2005 Feb; 19(1):137-40. PubMed ID: 15659147
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induction therapy with OKT3 in pediatric liver-transplant recipients.
    Ryckman FC; Schroeder TJ; Pedersen SH; Dittrich VS; Balistreri WF
    Transplant Sci; 1994 Dec; 4 Suppl 1():S20-5. PubMed ID: 7627451
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.